Dignass, Axel <br/><br/>
Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial.  [electronic resource] 

 -  Journal of Crohn's & colitis  Sep 2014 
 - 970-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1876-4479 
<br/><br/><label>Standard No.: </label>10.1016/j.crohns.2014.01.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Aged<br/>Budesonide--administration & dosage<br/>Crohn Disease--drug therapy<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Endoscopy, Gastrointestinal<br/>Female<br/>Follow-Up Studies<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Intestinal Mucosa--pathology<br/>Male<br/>Middle Aged<br/>Patient Compliance<br/>Prospective Studies<br/>Remission Induction<br/>Treatment Outcome<br/>Young Adult